Total Funding
56
45
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
56317
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.
Charles Stacey: President and CEO
Samuel Henderson: Vice President, Research & DevelopmentPast Role: GenoPlex, Lead Scientist
About the Company
Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases. It offers Ketasyn, a molecule for Alzheimer's, Parkinson's, and age-associated memory impairment.
It was founded in 2001 and is headquartered in Broomfield, Colorado.
